Drug Patent Expirations in May 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in May 2009

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ADENOSCAN Astellas adenosine 5,070,877 May 18, 2009
CELLCEPT Roche Palo mycophenolate mofetil 4,753,935 May 3, 2009
CELLCEPT Roche Palo mycophenolate mofetil hydrochloride 4,753,935 May 3, 2009
CLOLAR Genzyme clofarabine 5,384,310 May 23, 2009
COMTAN Orion entacapone 5,112,861 May 12, 2009
STALEVO 100 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
STALEVO 125 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
STALEVO 150 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
STALEVO 200 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
STALEVO 50 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
STALEVO 75 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009
ZANTAC Glaxosmithkline ranitidine hydrochloride 5,068,249 May 26, 2009

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.


Leave a Reply